HCA Healthcare (NYSE:HCA) Price Target Raised to $468.00

HCA Healthcare (NYSE:HCA – Get Free Report) had its target price raised by equities researchers at Wells Fargo & Company from $381.00 to $468.00 in a report issued on Monday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target would suggest a potential downside of 1.04% from the company’s current price.

HCA has been the subject of several other research reports. Mizuho set a $495.00 price target on HCA Healthcare in a research report on Wednesday. KeyCorp raised their price objective on shares of HCA Healthcare from $435.00 to $490.00 and gave the company an “overweight” rating in a research note on Wednesday, October 28th. The Goldman Sachs Group decreased their target price on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a report on Tuesday, July 28th. Deutsche Bank Aktiengesellschaft set a $476.00 price target on shares of HCA Healthcare in a report on Monday, July 27th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $479.48.

Check Out Our Latest Research Report on HCA Healthcare

HCA Healthcare Stock Down 0.1%

HCA stock opened at $472.94 on Monday. HCA Healthcare has a twelve month low of $353.99 and a twelve month high of $556.52. The firm has a market cap of $98.79 billion, a PE ratio of 15.67, a price-to-earnings-growth ratio of 1.58 and a beta of 1.11. The business has a 50 day moving average of $437.44 and a 200 day moving average of $444.90.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The business had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. During the same period in the previous year, the company posted $6.96 earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, research analysts expect that HCA Healthcare will post 30.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On HCA Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in shares of HCA Healthcare during the 2nd quarter valued at $5,069,974,000. Wellington Management Group LLP increased its position in HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the last quarter. Darsana Capital Partners LP lifted its holdings in HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after acquiring an additional 350,000 shares during the period. Legal & General Group Plc bought a new position in HCA Healthcare in the second quarter valued at about $410,992,000. Finally, Jupiter Topco LLC purchased a new position in HCA Healthcare in the second quarter worth about $371,138,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Recommended Stories

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.